Human association studies of common genetic polymorphisms have identified many loci that are associated with risk of complex diseases, although individual loci typically have small effects. However, by envisaging genetic associations in terms of cellular pathways, rather than any specific polymorphism, combined effects of many biologically relevant alleles can be detected. The effects are likely to be most apparent in investigations of phenotypically homogenous subtypes of complex diseases. We report findings from a case-control, genetic association study of relationships between 2925 single nucleotide polymorphisms (SNPs) and 2 subtypes of a commonly occurring chronic facial pain condition, temporomandibular disorder (TMD): 1) localized TMD and 2) TMD with widespread pain. When compared to healthy controls, cases with localized TMD differed in allelic frequency of SNPs that mapped to a serotonergic receptor pathway (P = 0.0012), while cases of TMD with widespread pain differed in allelic frequency of SNPs that mapped to a T-cell receptor pathway (P = 0.0014). A risk index representing combined effects of 6 SNPs from the serotonergic pathway was associated with greater odds of localized TMD (odds ratio 2.7, P = 1.3 E-09), and the result was reproduced in a replication case-control cohort study of 639 people (odds ratio 1.6, P = 0.014). A risk index representing combined effects of 8 SNPs from the T-cell receptor pathway was associated with greater odds of TMD with widespread pain (P = 1.9 E-08), although the result was not significant in the replication cohort. These findings illustrate potential for clinical classification of chronic pain based on distinct molecular profiles and genetic background. Ó
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Introduction
Temporomandibular disorder (TMD) is a commonly occurring clinical condition characterized by pain in the temporomandibular joints and the masticatory muscles. In the U.S. population, TMD symptoms affect 3% of men and 6% of women [10], and incidence of 3.5% per annum has been reported in women [37] . Diverse treatments, including surgical and behavioral interventions, are used to treat TMD, although evidence of efficacy is equivocal for some of them [4] and no medicines have been approved specifically for TMD. Despite its burden in the population, the pathophysiology of TMD remains largely unknown [5] . More fundamentally, it is not clear whether TMD should be regarded as a facial-regional pain condition, or whether TMD is a manifestation of other widespread pain syndromes such as fibromyalgia and chronic widespread pain [47] . Evidence for the latter comes from the clinical observation that TMD patients often present with other chronic pain conditions. Furthermore, clinical studies show that TMD patients are sensitive to a wide range of experimental pain modalities outside of the facial area [5, 17, 18] . This enhanced sensitivity has been attributed to pathological changes in central pain processing such as sensitization of spinal nociceptive neurons and disturbances of descending noxious control systems [9, 26] .
